Study the Role of Genetic Variation in the Determining Lipid Profile Response to Dietary Change

This study has been completed.
Sponsor:
Information provided by:
Tabriz University
ClinicalTrials.gov Identifier:
NCT00673023
First received: May 4, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
  Purpose

The purpose of this study is to determine whether plasma lipoproteins and lipid responsiveness to a dietary modification is influenced by CETP gene polymorphism.


Condition Intervention
Metabolic Syndrome
Other: Dietary experiments

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Study the Role of Polymorphism at the CETP Gene Locuse in the Determining Lipid Profile Response to Dietary Change

Resource links provided by NLM:


Further study details as provided by Tabriz University:

Enrollment: 102
Study Start Date: October 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet
Experimental: 2 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet
Experimental: 3 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy Volunteers

Exclusion Criteria:

  • History of any cardiovascular diseases
  • type 1 diabetes
  • type 2 diabetes
  • use of lipid-lowering medications
  • hypertension
  • pregnancy
  • Current intake of vitamins and supplements
  • History of endocrin disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00673023

Sponsors and Collaborators
Tabriz University
Investigators
Study Director: Mohammad Noori, PhD Tabriz University
  More Information

No publications provided

Responsible Party: vice-chancellor for reseach, Tabriz University, Deputy of Research
ClinicalTrials.gov Identifier: NCT00673023     History of Changes
Other Study ID Numbers: 8641
Study First Received: May 4, 2008
Last Updated: May 4, 2008
Health Authority: Iran: Ministry of Health

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 26, 2014